Search Tag: Anthracycline Cardiotoxicity

2024 17 Sep

  The RESILIENCE clinical trial aims to assess the safety and effectiveness of remote ischaemic conditioning (RIC) in preventing the cardiotoxic effects of anthracycline-based chemotherapy in lymphoma patients. This trial is expected to provide critical insights and potential solutions for a major clinical challenge.   Anthracycline-induced cardiotoxicity...Read more